Sparrow Pharmaceuticals
Clinical trials sponsored by Sparrow Pharmaceuticals, explained in plain language.
-
New drug tested to tame dangerous hormone flood
Disease control CompletedThis study tested an investigational drug called SPI-62 to see if it could safely reduce the harmful excess cortisol caused by ACTH-dependent Cushing's syndrome. For 24 weeks, 26 adult participants received either the drug or a placebo, with an option to continue on the drug long…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New pill targets hidden hormone havoc from adrenal tumors
Disease control CompletedThis study tested whether a daily pill called SPI-62 could help control the health problems caused by too much cortisol from a benign adrenal tumor. It involved 30 adults who had both high cortisol and related issues like high blood sugar, high cholesterol, or bone thinning. Rese…
Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Scientists test new Drug's safety mix with sedative and steroid
Knowledge-focused CompletedThis study aims to see if a new drug called clofutriben changes how the body handles two other common drugs, midazolam (a sedative) and prednisolone (a steroid). It involved 16 healthy adults who took all three drugs while researchers took many blood, urine, and stool samples to …
Phase: PHASE1 • Sponsor: Sparrow Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC